Suitability of tablets according to the recent EMA/CHMP draft ‘Guideline on pharmaceutical development of medicines for paediatric use’6
| Age categories (EMA/CHMP reflection paper)4 | Age | Acceptability of tablets |
|---|---|---|
| Neonates | 0–30 days | None |
| Infants | 1–6 months | None |
| 6–24 months | None; but powders, granules and pellets accepted | |
| Preschool children | 2–5 years | Tablets 3–5 mm in diameter |
| School children | 6–11 years | Tablets ≤10 mm in diameter |
| 12–18 years | Tablets ≤15 mm in diameter |
CHMP, Committee for Medicinal Products for Human Use; EMA, European Medicines Agency.